Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review

For a long time, cisplatin-based chemotherapy had been viewed as first-line chemotherapy for advanced and metastatic urothelial carcinoma (UC). However, many patients with UC had been classified as cisplatin-ineligible who can only receive alternative chemotherapy with poor treatment response, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huang-Yu, Wu, Chao-Yi, Chen, Jia-Jin, Lee, Tao-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730311/
https://www.ncbi.nlm.nih.gov/pubmed/33256165
http://dx.doi.org/10.3390/ijms21238993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730311/
https://www.ncbi.nlm.nih.gov/pubmed/33256165
http://dx.doi.org/10.3390/ijms21238993

Ejemplares similares